Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Pediatric Blood & Cancer
|
May 4, 2026
Intestinal Low-Dose Radiation to Overcome PD-1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
Shubham Sahni, Archana Sasi, Surendra Kumar Saini, et al.
Nutritional Neuroscience
|
September 29, 2025
Phytoconstituents of Indian mustard honey impart antidepressant activity in reserpine-induced depressed condition through activation of TrkB/CREB/BDNF pathway in hippocampus
Saakshi Saini, Viney Kumar, Samrat Chauhan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2025
A study of curative approach treatment along with metastasis-directed SBRT in bone-only oligometastatic breast cancer
Abhilash Dagar, Adrija Ghosh, Abhinav Singhal, et al.
Trials
|
February 26, 2025
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)
Adhip Arora, V Seenu, Rajinder Parshad, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Pediatric Blood & Cancer
|
May 4, 2026
Intestinal Low-Dose Radiation to Overcome PD-1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
Shubham Sahni, Archana Sasi, Surendra Kumar Saini, et al.
Nutritional Neuroscience
|
September 29, 2025
Phytoconstituents of Indian mustard honey impart antidepressant activity in reserpine-induced depressed condition through activation of TrkB/CREB/BDNF pathway in hippocampus
Saakshi Saini, Viney Kumar, Samrat Chauhan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2025
A study of curative approach treatment along with metastasis-directed SBRT in bone-only oligometastatic breast cancer
Abhilash Dagar, Adrija Ghosh, Abhinav Singhal, et al.
Trials
|
February 26, 2025
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)
Adhip Arora, V Seenu, Rajinder Parshad, et al.
Page
of 2